Hopp til innhold

Get alerts of updates about «Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective

Project

Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective - project description

Published Updated

The aim of this study was to explore all Brucella melitensis isolates collected in Norway from 1999 to 2016 in relation to origin of infection and antimicrobial resistance patterns.


Summary

Brucellosis is a rarely encountered infection in Norway. The aim of this study was to explore all Brucella melitensis isolates collected in Norway from 1999 to 2016 in relation to origin of infection and antimicrobial resistance patterns. A total of 23 isolates were analysed by whole-genome sequencing and compared with selected sequences of B. melitensis available from NCBI. Additionally, SNP analysis in antibiotic resistance determining genes was performed. The majority belonged to the East Mediterranean clade (genotype II), while the remaining isolates belonged to the African clade (genotype III). These results indicate that human brucellosis in Norway is related to travels or migration from the Middle East, Asia or Africa, in accordance with results from Germany, Denmark and Sweden. Antibiotic susceptibility patterns were determined by broth microdilution method and/or gradient strip method. All isolates were susceptible for all tested antibiotics, except for rifampicin where phenotypical results indicated resistance or intermediate resistance in all isolates based on broth microdilution method, and in four isolates based on gradient strip testing. In contrast, screening of the rpoB gene did not reveal any mutations in the previously described rpoB “hot spot“regions related to rifampicin resistance, indicating overestimation of resistance based on phenotypical results.

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Tone Kristin Bjordal Johansen, Avdeling for smitte fra mat, vann og dyr, Norwegian Institute of Public Health

Project participants

Siri Laura Feruglio, Avdeling for smitte fra mat, vann og dyr, Norwegian Institute of Public Health
Veronica Klausmark Jensen, Avdeling for bakteriologi, Norwegian Institute of Public Health
Jon Bohlin, Avdeling for infeksjonsepidemiologi og modellering, Norwegian Institute of Public Health
Lonneke Scheffer, University of Oslo

Start

01.03.2016

End

31.05.2021

Status

Active

Approvals

Regional committees for medical and health research ethics

Project owner/ Project manager

Norwegian Institute of Public Health